| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA642007 | F | Agonistic activity measures the ability to induce alkaline phosphatase in T47D human breast cancer cell line | 19 | cell-based format | Scientific Literature | |||
| 2. | ALA642008 | F | Efficacy in vitro relative to Mifepristone in progesterone receptor induced alkaline phosphatase T47D cell assay | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 3. | ALA642160 | F | Efficacy in vitro relative to P4 in progesterone receptor induced alkaline phosphatase T47D cell assay | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
| 4. | ALA875251 | F | Ability to block progesterone induced alkaline phosphatase activity in T47D human breast cancer cell line | 20 | cell-based format | Scientific Literature | |||
| 5. | ALA642162 | F | Antagonistic potency to the human progesterone receptor measured in the T-47D alkaline phosphatase assay | 28 | assay format | Scientific Literature | |||
| 6. | ALA642163 | F | Antagonistic efficacy to the progesterone receptor measured in the T-47D alkaline phosphatase assay | 28 | assay format | Scientific Literature | |||
| 7. | ALA653488 | F | Effective concentration (EC50) against human progesterone receptor expressed in CV-1 cell | Homo sapiens | 24 | cell-based format | Scientific Literature | ||
| 8. | ALA656175 | B | Inhibitory concentration against progesterone induced PRE-luciferase activity in CV-cells | Oryctolagus cuniculus | 13 | assay format | Scientific Literature | ||
| 9. | ALA656176 | B | Inhibitory concentration against progesterone induced transcriptional activity in CV-1 cells; ND is not determined | 3 | cell-based format | Scientific Literature | |||
| 10. | ALA749958 | F | In vitro antagonist potency in transactivation assay in neuroblastoma cells expressing human PR-A progesterone receptor | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 11. | ALA749962 | F | In vitro antagonist potency in transactivation assay in neuroblastoma cells expressing human PR-B progesterone receptor | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 12. | ALA749963 | F | In vitro antagonist potency in transactivation assay in neuroblastoma cells expressing human PR-A progesterone receptor | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 13. | ALA750122 | F | In vitro antagonist potency in transactivation assay in neuroblastoma cells expressing human PR-B progesterone receptor | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 14. | ALA750123 | F | In vitro agonist potency in transactivation assay in neuroblastoma cells expressing human PR-A progesterone receptor; NE=no effect | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 15. | ALA749308 | F | In vitro agonist potency in transactivation assay of neuroblastoma cells expressing human PR-B progesterone receptor; NE=no effect | Homo sapiens | 1 | assay format | Scientific Literature | ||
| 16. | ALA749309 | F | In vitro agonist potency in transactivation assay of neuroblastoma cells expressing human PR-A progesterone receptor | Homo sapiens | 1 | assay format | Scientific Literature | ||
| 17. | ALA749313 | F | In vitro agonist potency in transactivation assay in neuroblastoma cells expressing human PR-B progesterone receptor | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 18. | ALA762711 | B | Binding affinity towards progesterone receptor (PR) by displacing [3H]progesterone. | 24 | single protein format | Scientific Literature | |||
| 19. | ALA763298 | F | Agonist efficacy for human progesterone receptor in T47D human breast cancer cell; not active (<20% efficacy and/or >10 mM potency) | Homo sapiens | 3 | cell-based format | Scientific Literature | ||
| 20. | ALA763299 | B | Binding affinity to progesterone receptor of MCF-7 cytosols (human breast cancer cells) | Homo sapiens | 8 | cell-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!